ClinConnect ClinConnect Logo
Search / Trial NCT06876181

In Vivo Study of Local Tranexamic Acid Concentrations Following Intra-Articular Administration in Total Knee Arthroplasty

Launched by VALDOLTRA ORTHOPEDIC HOSPITAL · Mar 9, 2025

Trial Information

Current as of April 26, 2025

Completed

Keywords

Tranexamic Acid Intra Articular Administration Topical Administration Local Concentration Elimination Half Time

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • diagnosis of advanced osteoarthritis of the knee joint
  • Exclusion Criteria:
  • known allergy to TXA
  • family history or past spontaneous thromboembolic event
  • pathological preoperative blood analysis
  • advanced heart failure (NYHA \> 2)
  • ischemic heart disease
  • epilepsy

About Valdoltra Orthopedic Hospital

Valdoltra Orthopedic Hospital is a leading medical institution specializing in orthopedic care and innovative research. Renowned for its commitment to advancing orthopedic practices, the hospital conducts clinical trials aimed at evaluating new treatments, surgical techniques, and rehabilitation methods. With a team of experienced professionals and a state-of-the-art facility, Valdoltra fosters a collaborative environment that prioritizes patient safety and outcomes. The hospital's dedication to excellence in clinical research contributes significantly to the advancement of orthopedic medicine, ensuring that patients receive the most effective and evidence-based care.

Locations

Ankaran, Ajdovscina, Slovenia

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported